176 related articles for article (PubMed ID: 36580262)
1. Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch1.
Chen M; Pan Y; Liu H; Ning F; Lu Q; Duan Y; Gan X; Lu S; Hou H; Zhang M; Tian Y; Lash GE
Cell Oncol (Dordr); 2023 Jun; 46(3):571-587. PubMed ID: 36580262
[TBL] [Abstract][Full Text] [Related]
2. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
3. Cancer/testis antigen-Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway.
Li Y; Chu J; Li J; Feng W; Yang F; Wang Y; Zhang Y; Sun C; Yang M; Vasilatos SN; Huang Y; Fu Z; Yin Y
Mol Oncol; 2018 Aug; 12(8):1233-1248. PubMed ID: 29704427
[TBL] [Abstract][Full Text] [Related]
4. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
[TBL] [Abstract][Full Text] [Related]
5. Paeoniflorin influences breast cancer cell proliferation and invasion via inhibition of the Notch‑1 signaling pathway.
Zhang J; Yu K; Han X; Zhen L; Liu M; Zhang X; Ren Y; Shi J
Mol Med Rep; 2018 Jan; 17(1):1321-1325. PubMed ID: 29115554
[TBL] [Abstract][Full Text] [Related]
6. Ezrin promotes breast cancer progression by modulating AKT signals.
Li N; Kong J; Lin Z; Yang Y; Jin T; Xu M; Sun J; Chen L
Br J Cancer; 2019 Apr; 120(7):703-713. PubMed ID: 30804430
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway.
Wang B; Wang Y; Wang X; Gu J; Wu W; Wu H; Wang Q; Zhou D
Dis Markers; 2022; 2022():5762686. PubMed ID: 35655918
[TBL] [Abstract][Full Text] [Related]
8. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract][Full Text] [Related]
9. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
[TBL] [Abstract][Full Text] [Related]
10. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
11. HES1-mediated down-regulation of miR-138 sustains NOTCH1 activation and promotes proliferation and invasion in renal cell carcinoma.
Liu S; Dou L; Miao M; Man X; Wei B; Jiang Z; Ouyang Y; Ozaki T; Yu M; Zhu Y
J Exp Clin Cancer Res; 2023 Mar; 42(1):72. PubMed ID: 36973704
[TBL] [Abstract][Full Text] [Related]
12. CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling.
Zeng JS; Zhang ZD; Pei L; Bai ZZ; Yang Y; Yang H; Tian QH
Int J Biochem Cell Biol; 2018 Feb; 95():1-8. PubMed ID: 29229426
[TBL] [Abstract][Full Text] [Related]
13. Myeloid Notch1 deficiency activates the RhoA/ROCK pathway and aggravates hepatocellular damage in mouse ischemic livers.
Lu L; Yue S; Jiang L; Li C; Zhu Q; Ke M; Lu H; Wang X; Busuttil RW; Ying QL; Kupiec-Weglinski JW; Ke B
Hepatology; 2018 Mar; 67(3):1041-1055. PubMed ID: 29024000
[TBL] [Abstract][Full Text] [Related]
14. A novel role for ezrin in breast cancer angio/lymphangiogenesis.
Ghaffari A; Hoskin V; Szeto A; Hum M; Liaghati N; Nakatsu K; LeBrun D; Madarnas Y; Sengupta S; Elliott BE
Breast Cancer Res; 2014 Sep; 16(5):438. PubMed ID: 25231728
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of miR-1179 inhibits breast cancer cell metastasis by modulating Notch signaling pathway and correlates with favorable prognosis.
Li WJ; Xie XX; Bai J; Wang C; Zhao L; Jiang DQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8374-8382. PubMed ID: 30556878
[TBL] [Abstract][Full Text] [Related]
16. Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression.
Zhang Q; Zhu Z; Guan J; Hu Y; Zhou W; Ye W; Lin B; Weng S; Chen Y; Zheng C
Mol Biotechnol; 2022 Dec; 64(12):1419-1430. PubMed ID: 35704163
[TBL] [Abstract][Full Text] [Related]
17. Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells.
Soylu H; Kırca M; Avcı S; Ozpolat B; Ustunel I
Exp Mol Pathol; 2021 Apr; 119():104607. PubMed ID: 33482170
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation-mediated activation of cancer/testis antigen KK-LC-1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling.
Chen Z; Zuo X; Pu L; Zhang Y; Han G; Zhang L; Wu Z; You W; Qin J; Dai X; Shen H; Wang X; Wu J
Cell Prolif; 2019 May; 52(3):e12581. PubMed ID: 30895661
[TBL] [Abstract][Full Text] [Related]
19. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
[TBL] [Abstract][Full Text] [Related]
20. Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers.
Sun Y; Gao X; Liu J; Kong QY; Wang XW; Chen XY; Wang Q; Cheng YF; Qu XX; Li H
Arch Pathol Lab Med; 2011 Apr; 135(4):451-8. PubMed ID: 21466361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
